S&P 500 · Health Care · USD · FY end 2025-12-31
Idexx Laboratories (IDXX) financials — revenue, earnings, margins, balance sheet, cash flow and dividends. 10-year history sourced from SEC filings.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| FY2025 | 4.30B | 1.06B | 13.08 | 1.06B |
| FY2024 | 3.90B | 887.87M | 10.67 | 808.08M |
| FY2023 | 3.66B | 845.04M | 10.06 | 772.88M |
| FY2022 | 3.37B | 679.09M | 8.03 | 394.15M |
| FY2021 | 3.22B | 744.85M | 8.60 | 636.00M |